Profile
Scott Lauder worked as VP-Process Sciences & Clinical Manufacturing at Merrimack Pharmaceuticals, Inc. from 2013 to 2016.
He then worked as Chief Technology Officer at Gemini Therapeutics, Inc. from 2016 to 2021.
Lauder holds a doctorate degree from Northwestern University and an undergraduate degree from the University of Manitoba.
Former positions of Scott Lauder
| Companies | Position | End |
|---|---|---|
| GEMI THER | Chief Tech/Sci/R&D Officer | 2021-09-16 |
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2016-09-30 |
Training of Scott Lauder
| University of Manitoba | Undergraduate Degree |
| Northwestern University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Scott Lauder
